Solstice Advanced Materials Inc.
Company Information
Industry
Chemicals & Allied Products
SIC Code
2800
Entity Type
operating
SEC Category
Non-accelerated filer
State of Incorporation
DE
Business Address
115 TABOR ROAD, MORRIS PLAINS, NJ, 07950
Mailing Address
115 TABOR ROAD, MORRIS PLAINS, NJ, 07950
Phone
704-627-6200
Fiscal Year End
1231
EIN
332919563
Financial Overview
FY2025
$621.00M
Net Income
$5.67B
Total Assets
$4.30B
Total Liabilities
$661.00M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | April 2, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
Annual Reports
10-K
February 19, 2026
- Achieved $4.5 billion pro forma revenue and $320 million net income in its first independent year.
- Generated robust operating cash flow of $480 million, demonstrating strong financial health.
Related Companies
Companies in the same industry (SIC: 2800)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.